Serina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

HUNTSVILLE, AL, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform^™ drug optimization technology, announced that Steve Ledger, Chief Executive Officer, will present at the H.C. Wainwright 27^th Annual Global Investment Conference in New York, NY on September 8, 2025, at 9:30 a.m. ET.

Read more at globenewswire.com